The Federal Trade Commission secured an $18.2 million judgment against Danielle Cadiz in a case targeting Redwood Scientific Technologies and its RengaLife brand. This judgment, issued with a permanent injunction, remains suspended due to Cadiz's stated inability to pay.

Cadiz, who also uses the name Danielle Walker, faced charges alongside Jason and Eunjung Cardiff. The FTC complaint detailed a "fraudulent multi-pronged scheme" operated through Redwood Scientific Technologies, the parent entity of RengaLife. The agency alleged the trio targeted consumers with false health claims and unauthorized billing, accumulating millions in losses.

The permanent injunction imposes broad restrictions on Cadiz's future business activities. She cannot make any health claims regarding smoking cessation, weight loss, appetite suppression, sexual performance, or disease treatment. This prohibition extends to any unsubstantiated health pitches.

Cadiz is also forbidden from misrepresenting product tests, research results, or earnings potential. She cannot create false endorsements or mislead customers about product origins. Similarly, misrepresentations concerning customer satisfaction rates, total costs, refund policies, or product limitations are strictly prohibited.

Furthermore, Cadiz cannot employ robocalls or ringless voicemails for marketing. She cannot present products as "negative option" sales if they do not meet that definition. The injunction also prevents her from billing consumers without explicit, informed consent or initiating any unauthorized charges, including direct bank debits.

The $18.2 million monetary judgment against Cadiz is technically in place. However, it is suspended, meaning the FTC will not collect it, based on her sworn financial disclosures indicating an inability to pay. Cadiz must file compliance reports with the FTC for the next ten years, detailing any changes to her name, address, employment, or business interests.

Meanwhile, Jason and Eunjung Cardiff, identified as the owners of Redwood Scientific Technologies and RengaLife, continue their legal efforts to recover their passports. This dispute began in March, with no resolution announced yet.

A court order on May 21st directed both parties to schedule a settlement conference. The status of this conference remains undetermined.

The court-appointed Receiver for Redwood Scientific Technologies recently petitioned the court for authorization to involve law enforcement during visits to the Cardiff residence. The Receiver's duties include arranging for three independent appraisers to evaluate the property before its sale.

The Receiver reported that the Cardiffs have "stalled and prevented" him from carrying out his responsibilities. Their ongoing refusal to cooperate has already incurred costs for the receivership estate, including $36,500.25 in missed mortgage payments and additional legal fees associated with filing the motion.

Prior to April 30, 2019, the Receiver made several attempts to schedule appraisals. The Cardiffs responded with "obstructive and dilatory tactics," blocking access. After that date, the Receiver's legal team took over communications.

The Cardiffs eventually agreed on May 14th to allow the Receiver access on May 24th for a six-hour property evaluation. However, they cancelled this appointment on May 23rd, offering no explanation.

The Cardiffs then proposed a new date in August. The Receiver deemed this "unacceptable," citing accumulating mortgage and tax obligations on the property.

The Receiver's motion requests temporary possession of the residence solely for the purpose of completing the appraisal process. Given the Cardiffs' history of non-cooperation, the motion also seeks court authorization to request police assistance should they obstruct access again.

The court is currently reviewing the Receiver's motion, filed on June 10th.